The results of acute and sub-chronic toxicity of Hoai Ky LC powder in experiments

Xuân Trung Mai, Tiến Chung Nguyễn, Quốc Nghị Dương

Main Article Content

Abstract

Objective: To evaluate the acute and sub-chronic toxicity of Hoai ky LC powder in experiments.


Subjects and methods: An experimental research was conducted on Wistar rats and Swiss mice using Litchfield – Wilcoxon method, WHO and Ministry of Health guidelines. Hoai ky LC powder was produced at Lao Cai Traditional Medicine Hospital.


Results: Hoai ky LC powder did not show any acute toxicity at a dose of 31.25 g/kg/day on Swiss mice. The LD50 of Hoai ky LC powder taken orally has not been determined on Swiss mice. Hoai ky LC powder when administered orally for 4 consecutive weeks on Wistar rats at doses of 6g/kg/day and 12g/kg/day did not affect the general condition, hematological indices, liver and kidney function and microscopic structure of liver and kidney of Wistar rats.


Conclusion: Hoai ky LC powder is safe at the clinical dose of 50g/day.

Article Details

References

1. Phạm Quan Kiệt, Đặng Triệu Trí, Chủ Thẩm. Đái tháo đường. Lâm sàng trung y chẩn trị chuyên đề bệnh nội tiết, Nhà xuất bản Y học nhân dân Trung Quốc, 2013, tr.38.
2. Saganuwan, S. A. Toxicity studies of drugs and chemicals in animals: an overview. Bulgarian Journal of Veterinary Medicine, 2017, 4(20), pp.291-318.
3. OECD. Guidelines for the testing of chemicals repeated dose oral toxicity study in rodents. Environmental Health and Safety Monograph Series on Testing and Assesment No 407, 2008.
4. Gerhard Vogel H. Drug discovery and evaluation Pharmacological assays, Springer, 2016.
5. World Health Organization. Working group on the safety and efficacy of herbal medicine, Report of regional office for the western pacific of the World Health Organization, 2013.
6. Venkatasubbu GD, Ramasamy S, Gaddam PR, et al. Acute and subchronic toxicity analysis of surface modified paclitaxel attached hydroxyapatite and titanium dioxide nanoparticles. International Journal of Nanomedicine, 2015, 10, pp.137-148.
7. De Jong WH, Carraway JW and Geertsma RE. In vivo and in vitro testing for the biological safety evaluation of biomaterials and medical devices. Biocompatibility and Performance of Medical Devices, 2012, pp.120-158.
8. Quan Thế Dân. Nghiên cứu tác dụng của bài thuốc Bổ dương hoàn ngũ điều trị đái tháo đường týp 2 có biến chứng thận trong thực nghiệm và trên lâm sàng, Luận án Tiến sĩ y học, Trường đại học Y Hà Nội, 2015.